A Comparison of Peritonitis in Polycystic and Non-Polycystic Patients on Peritoneal Dialysis

Hadimeri H. , Johansson A-C , Haraldsson B. , Nyberg G. CAPD in patients with autosomal dominant polycystic kidney disease. Perit Dial Int 1998; 18: 429–32.

Pirson Y. Recent advances in the clinical management of autosomal dominant polycystic kidney disease. QJM 1996; 89: 803–6.

Pirson Y. , Christophe J.L. , Goffin E. Outcome of renal replacement therapy in autosomal dominant polycystic kidney disease. Nephrol Dial Transplant 1996; 11(Suppl 6): 24–8.

Zeier M. , Jones E. , Ritz E. Autosomal dominant polycystic kidney disease – the patient on renal replacement therapy. Nephrol Dial Transplant 1996; 11(Suppl 6): 18–20.

Van Biesen W. , Van Holder R. , Lameire N. Impact of pretransplantation dialysis modality on patient outcome after renal transplantation: The role of peritoneal dialysis revisited. Perit Dial Int 1999; 19: 103–6.

Locatelli A.J. , Marcos G.M. , Gomez M.G. , Alvarez S.A. , DeBenedetti L.C. Comparing peritonitis in continuous ambulatory peritoneal dialysis patients versus automated peritoneal dialysis patients. Adv Perit Dial 1999; 15: 193–6.

Singh S. , Harharan S. Renal replacement therapy in autosomal dominant polycystic kidney disease. Nephron 1991; 57: 40–4.

Standards Subcommittee of Renal Association. Treatment of adult patients with renal failure. Recommended standards and audit measures. 2nd ed. London: Royal College of Physicians of London, and The Renal Association; 1997, November: 37.

Windeler J. , Lange S. Events per person year – a dubious concept. BMJ 1995; 310: 454–6.

Glynn R.J. , Buring J.E. Ways of measuring rates of recurrent events. BMJ 1996; 312: 364–7.

Nolph K.D. , Cutler S.J. , Steinberg S.M. , Novak J.W. Continuous ambulatory peritoneal dialysis in the United States: A three year study. Kidney Int 1985; 28: 198–205.